Visit HCP Site Prescribing Information Important Safety Information

Individualized injection support from a GlatopaCare Nurse Trainer

Glatopa nurse trainer

We can help you feel more confident about self-injection and proper injection technique

Your GlatopaCare Nurse Trainer can show you how to use the Glatopaject^® injection device and give you tips and pointers on how to improve your injection experience.

Ways we can help with your Glatopa medication

Glatopaject Glatopa Injection Device for Copaxone Generic

Glatopaject injection device to help with proper administration

The Glatopaject injection device is included with your free Glatopa Starter Kit, which you will receive when you enroll in GlatopaCare.

Glatopaject works with the Glatopa prefilled syringe. It’s designed to work like other injection devices on the market, so using Glatopaject should feel familiar if you are switching from Copaxone^® (glatiramer acetate injection).

Glatopa injection training

Injection training at home or over the phone

Your GlatopaCare Nurse Trainer is happy to meet you at your home and provide instruction on how to administer Glatopa and use the Glatopaject injection device.

He or she can also provide instruction over the phone. Just call 1.855.GLATOPA (1.855.452.8672) to set up an appointment.

Your GlatopaCare Nurse Trainer will

Call you to schedule the training session
Show you the proper technique when using your Glatopaject injection device
Offer tips and pointers on when and where to inject
Provide injection guidance to improve your injection experience

Convenient support when it matters most

Glatopa injection support (Copaxone generic)

24/7 injection support

Nurse Trainers are available at any time to answer questions related to Glatopa and to provide guidance on injection sites, injection techniques, and administration.

Enroll in GlatopaCare patient support services here.

Call or text "ENROLL" to 1.855.GLATOPA (1.855.452.8672)

Indication

Glatopa^® (glatiramer acetate injection) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Important Safety Information

Do not take Glatopa^® if you are allergic to glatiramer acetate, mannitol, or any of the ingredients in Glatopa.

Some patients report a short-term reaction right after or within minutes after injecting glatiramer acetate. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heartbeat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.

Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.

A permanent indentation under the skin (lipoatrophy) or, rarely, necrosis at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

The most common side effects in studies of glatiramer acetate injection are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of glatiramer acetate. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking Glatopa.

To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see full Prescribing Information for Glatopa.

Glatopa, GlatopaCare, and Glatopaject are registered trademarks of Novartis AG.

Copaxone is a registered trademark of Teva Pharmaceutical Industries Ltd.

S-GLA-1381136 04/2020

Site Map Privacy Terms of Use Contact Us Sandoz Novartis